Related Experiment Video
Updated: Jul 18, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Antidepressant pharmacotherapy: considerations for the pain clinician
Kenneth C Jackson1, Erin L St Onge
1Texas Tech University Health Sciences Center, International Pain Institute at Texas Tech Medical Center, Lubbock, Texas 79430, USA. kenneth.jackson@ttmc.ttuhsc.edu
Abstract:
Antidepressant pharmacotherapy presents many challenges to clinicians dealing with patients suffering from chronic pain. Co-existent depression and pain continues to present clinicians with a plethora of difficult treatment selections. Treated in isolation, each of these disease states can prove difficult to treat. Collectively, depression and pain often present significantly more difficult challenges to the clinician. Antidepressants may be used as a primary treatment modality for depression in a patient dealing with chronic pain. At other times these agents may be used to treat certain specific chronic pain syndromes, possibly in the face of concomitant depression. Clinicians should be aware of the many peculiarities associated with this broad class of medications. Included in this review are considerations for drug selection, dose escalation, and common drug related problems (eg, adverse drug reactions). In addition, attention is paid to the appropriate selection of an agent for use in either the primary management of pain or depression.
Related Concept Videos
Analgesia and Pain Management
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Drug Therapy
Antianxiety Medications
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Antidepressant Drugs: MAOIs and Other Agents

